Vincula Biotech Group is a biotechnology ecosystem covering the entire chain of regenerative medicine and cell & gene therapy. We are a unique platform of research laboratories, biobanks, manufacturing facilities, authorized clinics and hospitals. Our goal is to transform innovative treatments into effective, standardized, personalized and accessible therapies. As the first privately-owned biotechnology group of its kind, we seamlessly integrate all the processes under centralized leadership and add the advantages of business logic and efficient project and financial management to the sector. Under the former name of Forever Young, Vincula Biotech Group acquired Educell and Biobanka (members of MBSI) and Parks surgical hospital, transforming itself into a holding of companies.